Skip to main content
TipRanks
Go Ultimate75% OFF

Santhera Pharmaceuticals Holding (SPHDF) Stock Statistics & Valuation Metrics

40 Followers

Total Valuation

Santhera Pharmaceuticals Holding has a market cap or net worth of $231.93M. The enterprise value is $271.86M.

Market Cap
$231.93M
Enterprise Value
$271.86M

Share Statistics

Santhera Pharmaceuticals Holding has 15,946,319 shares outstanding. The number of shares has increased by 12.29% in one year.

Shares Outstanding
15,946,319
Owned by Insiders
―
Owned by Institutions
0.63%

Financial Efficiency

Santhera Pharmaceuticals Holding’s return on equity (ROE) is 4.17 and return on invested capital (ROIC) is -37.53%.

Return on Equity (ROE)
4.17
Return on Assets (ROA)
-0.33
Return on Invested Capital (ROIC)
-37.53%
Return on Capital Employed (ROCE)
-0.44
Revenue Per Employee
989.55K
Profits Per Employee
-631.23K
Employee Count
78
Asset Turnover
0.52
Inventory Turnover
2.52

Valuation Ratios

The current PE Ratio of Santhera Pharmaceuticals Holding is -5.58. Santhera Pharmaceuticals Holding’s PEG ratio is -0.07.

PE Ratio
-5.58
PS Ratio
1.92
PB Ratio
-29.57
Price to FCF
341.59
Price to Operating Cash Flow
276.58
PEG Ratio
-0.07

Income Statement

In its last fiscal year, Santhera Pharmaceuticals Holding had revenue of 77.19M and earned -49.24M in profits. Earnings per share was -3.78.

Revenue
77.19M
Gross Profit
14.47M
Operating Income
-37.82M
Pretax Income
-49.05M
Net Income
-49.24M
EBITDA
-32.13M
Earnings Per Share (EPS)
-3.78

Cash Flow

In the last 12 months, operating cash flow was 660.00K and capital expenditures -90,000, giving a free cash flow of 570.00K.

Operating Cash Flow
660.00K
Free Cash Flow
570.00K
Free Cash Flow per Share
0.04

Dividends & Yields

Santhera Pharmaceuticals Holding pays an annual dividend of ―, resulting in a dividend yield of ―.

Dividend Per Share
―
Dividend Yield
―
Payout Ratio
N/A
Free Cash Flow Yield
0.29%
Earnings Yield
-17.49%

Stock Price Statistics

Beta
-0.44
52-Week Price Change
38.11%
50-Day Moving Average
18.69
200-Day Moving Average
21.59
Relative Strength Index (RSI)
0.07
Average Volume (3m)
355

Important Dates

Santhera Pharmaceuticals Holding upcoming earnings date is Apr 29, 2027, TBA (Not Confirmed).

Last Earnings Date
Sep 30, 2026
Next Earnings Date
Apr 29, 2027
Ex-Dividend Date
―

Financial Position

Santhera Pharmaceuticals Holding has a current ratio of 1.29, with a Debt / Equity ratio of -827.40%.

Current Ratio
1.29
Quick Ratio
0.89
Debt to Market Cap
0.53
Net Debt to EBITDA
-2.34
Interest Coverage Ratio
-3.27

Taxes

In its last fiscal year, Santhera Pharmaceuticals Holding paid 185.00K in taxes.

Income Tax
185.00K
Effective Tax Rate
-0.00

Enterprise Valuation

Santhera Pharmaceuticals Holding EV to EBITDA ratio is -57.82, with an EV/FCF ratio of 340.72.

EV to Sales
1.91
EV to EBITDA
-57.82
EV to Free Cash Flow
340.72
EV to Operating Cash Flow
294.26

Balance Sheet

Santhera Pharmaceuticals Holding has $41.77M in cash and marketable securities with $41.27M in debt, giving a net cash position of $494.00K.

Cash & Marketable Securities
$41.77M
Total Debt
$41.27M
Net Cash
$494.00K
Net Cash Per Share
$0.03
Tangible Book Value Per Share
-$4.71

Margins

Gross margin is 40.26%, with operating margin of -8.93%, and net profit margin of -31.46%.

Gross Margin
40.26%
Operating Margin
-8.93%
Pretax Margin
-31.32%
Net Profit Margin
-31.46%
EBITDA Margin
-3.31%
EBIT Margin
-8.93%

Analyst Forecast

Price Target
―
Price Target Upside
―
Analyst Consensus
―
Analyst Count
―
Revenue Growth Forecast
126.27%
EPS Growth Forecast
51.33%